ALBO

Albireo Pharma, Inc. Common Stock
ALBO

Overview Fund Activity
Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

22 hedge funds and large institutions have $2.61M invested in Albireo Pharma, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 5 closing their positions.

Holders
22
Holders Change
-2
Holders Change %
-8.33%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
5
Closed
5
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
-$13K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$1.7M
2
BFA
2
BlackRock Fund Advisors
California
$55K
3
PAM
3
Panagora Asset Management
Massachusetts
$47K
4
UBS Group
4
UBS Group
Switzerland
$12K
5
TSS
5
Two Sigma Securities
New York
$6K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$602K
2
VKH
2
Virtu KCG Holdings
New York
$5K
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$20K
5
Group One Trading
5
Group One Trading
Illinois
$22K
Name Market Value Shares Shares
Change 		Shares
Change %
Wells Fargo
26
Wells Fargo
California
$0 250 +250 New
Bank of America
27
Bank of America
North Carolina
$0 1,303 +557 +75%
1
2